Tree of Life Seeds - Article on - Arkansas Times - FDA Limits CBD advertising

FDA limits CBD advertising

This article first appeared on arktimes.com (Feb 8, 2018).

A company recently sent the Arkansas Times a press release advertising its cannabidiol (CBD) products, claiming they help with “relief of chronic pain,” “anti-inflammatory benefits,” “anxiety relief,” “sleep,” and “Cancer, Parkinson’s, and Diabetes fighting properties.”

Making such claims is against FDA guidelines. The FDA is researching cannabidiol “as a new drug for which substantial clinical investigations have been instituted and for which the existence of such investigations has been made public.” Therefore, you cannot sell CBD as a dietary supplement — it’s a drug. The FDA recently wrote warnings to a group of CBD sellers about this.

But that doesn’t mean CBD products can’t be sold. They just can’t be sold as dietary supplements or vitamins. It’s about the advertising.

The Times asked the Arkansas attorney general’s office whether it would take action against someone advertising CBD products for health purposes. It issued this statement:

“The Attorney General’s Office takes every false advertising complaint seriously. Our Consumer Protection Division investigates all allegations regardless of the nature…

READ MORE of this Article on arktimes.com